Lamivir HBV 100 mg (Lamivudine)
Lamivir HBV 100 mg (Lamivudine) | Variation | Price | Price / Unit | Quantity | Add To Cart |
|---|---|---|---|---|
| 30 Tablet/s | $75.00 | $2.5/ Piece | ||
| 60 Tablet/s | $144.00 | $2.4/ Piece | ||
| 90 Tablet/s | $207.00 | $2.3/ Piece | ||
| Active Ingredient (Generic Name): | Lamivudine |
| Manufacturer: | Cipla Limited |
| Packaging: | 10 tablets in 1 strip |
| Strength: | 100 MG |
| Delivery Time: | 6 To 15 days |
| SKU: | Lamivir HBV 100 mg (Lamivudine) |
Product details
| Quantity Value |
30 Tablet/s ,60 Tablet/s ,90 Tablet/s |
|---|
Description
Customer Reviews
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Lamivir HBV 100 mg (Lamivudine)” Cancel reply
Related Products
Select options
This product has multiple variants. The options may be chosen on the product page
Afatinib 40 mg
$168.00 – $487.00Price range: $168.00 through $487.00
Select options
This product has multiple variants. The options may be chosen on the product page
Flutamide 250 mg
$75.00 – $180.00Price range: $75.00 through $180.00
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
CA Atra 10 Softgel Capsule
$300.00 – $750.00Price range: $300.00 through $750.00
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page

Reviews
Clear filtersThere are no reviews yet.